Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event

Background: Long-acting beta2-agonists (LABAs), with or without inhaled corticosteroids (ICSs), delivered by handheld inhalers or nebulizers are recommended as maintenance therapy in chronic obstructive pulmonary disease (COPD). This study evaluated exacerbations, health resource utilization (HRU),...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chronic Obstr Pulm Dis
Main Authors: Navaie, Maryam, Celli, Bartolome R., Xu, Zhun, Cho-Reyes, Soojin, Dembek, Carole, Gilmer, Todd P.
Formato: Artigo
Idioma:Inglês
Publicado em: COPD Foundation Inc 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006702/
https://ncbi.nlm.nih.gov/pubmed/31483988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.4.2019.0127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados